(Q33443268)

English

Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

Sylvain Le Jeune

object named as

Sylvain Le Jeune

2

0 references

Jean-Jacques Mourad

object named as

Jean-Jacques Mourad

1

1 reference

ORCID Public Data File 2021

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

419-425

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pharmacological management of hypertension.

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200929060-00005

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global burden of blood-pressure-related disease, 2001.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The paradigm has shifted to systolic blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systolic pressure is all that matters

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200929060-00005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33443268&oldid=1951663633"